Antiretroviral Treatment Simplification With 2-Drug Regimens: Impact of Transmitted Drug Resistance Mutations

The frequency of clinically relevant transmitted drug resistance mutations (DRMs) against drugs used for 2-drug regimens was 15.6%, but only 2% were not eligible for 1 or more 2-drug regimens. More than 50% of patients harboring any clinically relevant DRMs were found to be part of genetic transmiss...

Descripción completa

Detalles Bibliográficos
Autores principales: Kessler, Harald H, Stelzl, Evelyn, Blažič, Anja, Mehta, Sanjay R, Benezeder, Anna S, Genger-Hackl, Christina, Santner, Brigitte I, Chaillon, Antoine, Hoenigl, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942491/
https://www.ncbi.nlm.nih.gov/pubmed/31915716
http://dx.doi.org/10.1093/ofid/ofz535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942491/
https://www.ncbi.nlm.nih.gov/pubmed/31915716
http://dx.doi.org/10.1093/ofid/ofz535

Ejemplares similares